Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain
Open Access
- 29 April 2021
- journal article
- research article
- Published by SAGE Publications in Therapeutic Advances in Musculoskeletal Disease
- Vol. 13
Abstract
Background: Opioids are widely used in moderate-to-severe chronic pain which is non-responsive to standard analgesics. Prescriptions have increased in Europe in the last decade, although remain lower than in USA. This work projected the future utilization and costs of opioids in chronic osteoarthritis (OA) pain in the Spanish National Health System (NHS). Methods: An epidemiological model was populated with the opioid dispensing trends from 2010 to 2019 using Spanish Medicinal Agency rates of opioid utilization in subjects over 18 years of age and the real-world OPIOIDS study to estimate chronic-OA-pain patients receiving opioids. A best-fitted trend analysis model was applied estimating the likely number of DHD (defined daily dose/1000 inhabitants per day) to calculate projected opioid utilization and costs for the period 2020–2029. Results: In 2010, an estimated 5.67 DHD were dispensed for the equivalent of 217,076 chronic OA pain patients per day [1.99 DHD, 76,084 refractory to non-steroidal anti-inflammatory drugs (NSAIDs)]. From these trends and OA prevalence, the projected number of DHDs is expected to increase more than threefold to 17.98 DHDs by the year 2029 for the equivalent of 727,356 chronic OA pain patients per day (8.18 DHD, 330,720 refractory to NSAIDs); 41.8% on strong opioids. The estimated cost was €116.9m (€45.0m in NSAID-refractory OA) in 2010 rising by 222% to €376.1m (€199.7m refractory to NSAIDs) by 2029. Conclusion: Chronic-OA-pain-related opioid dispensing and costs to the NHS are set to increase more than threefold from 2010 to 2029 in Spain. Using opioids for OA pain is concerning given disease chronicity and other related costs not computed in these projections.Keywords
This publication has 43 references indexed in Scilit:
- Socio-economic costs of osteoarthritis: A systematic review of cost-of-illness studiesSeminars in Arthritis and Rheumatism, 2015
- Trends in Prescription of Opioids From 2003–2009 in Persons With Knee OsteoarthritisArthritis Care & Research, 2014
- Management of Osteoarthritis in General Practice in AustraliaArthritis Care & Research, 2013
- The Global Economic Cost of Osteoarthritis: How the UK ComparesArthritis, 2012
- Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairmentBritish Journal of Clinical Pharmacology, 2011
- Spanish recommendations on economic evaluation of health technologiesThe European Journal of Health Economics, 2010
- Economic burden of knee and hip osteoarthritis in spainArthritis Care & Research, 2009
- Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatmentEuropean journal of pain, 2006
- The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this conditionRheumatology, 2005
- Prevalence of pain in the Spanish population telephone survey in 5000 homesEuropean journal of pain, 2002